Medication use and risk of reflux oesophagitis
RO was present in 11.8% of patients. Use of CCBs, theophylline, and NSAIDs were independent predictors of RO.
Authors
- Chizu Yokoi (ORCID: https://orcid.org/0000-0001-6642-4218)
- Yuriko Nishiie
- Hidetaka Okubo (ORCID: https://orcid.org/0000-0003-4271-2578)
- Yuka Yanai
- Ren Ueta (ORCID: https://orcid.org/0000-0003-2449-6859)
- Keigo Suzuki (ORCID: https://orcid.org/0000-0002-3013-6780)
- Masahiro Hata (ORCID: https://orcid.org/0000-0002-3836-3515)
- Kana Seto
- Yuki Otake
- Yuya Hisada (ORCID: https://orcid.org/0000-0002-0934-8690)
- Naoki Akazawa (ORCID: https://orcid.org/0000-0001-7330-4353)
- Kumiko Umemoto (ORCID: https://orcid.org/0000-0001-8901-7332)
- Kazuhiro Watanabe (ORCID: https://orcid.org/0000-0002-3342-6142)
- Shiori Komori
- Erika Masuda
- Junichi Akiyama
Institutions
- National Center for Global Health and Medicine (JP)
Publication Details
- Journal
- BMJ Open Gastroenterology
- Published
- 2024-12-01
- DOI
- https://doi.org/10.1136/bmjgast-2024-001468
- Primary Topic
- Gastroesophageal reflux and treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00